Published in J Rheumatol on February 01, 2005
Idiopathic nonspecific interstitial pneumonia: lung manifestation of undifferentiated connective tissue disease? Am J Respir Crit Care Med (2007) 2.69
Undifferentiated connective tissue disease: a seven-center cross-sectional study of 184 patients. Clin Rheumatol (2009) 1.19
Undifferentiated connective tissue disease-associated interstitial lung disease: changes in lung function. Lung (2010) 1.11
Early systemic sclerosis: short-term disease evolution and factors predicting the development of new manifestations of organ involvement. Arthritis Res Ther (2012) 0.81
Undifferentiated connective tissue disease presenting with prevalent interstitial lung disease: case report and review of literature. Diagn Pathol (2011) 0.80
Quality of life as measured by the short-form 36 (SF-36) questionnaire in patients with early systemic sclerosis and undifferentiated connective tissue disease. Health Qual Life Outcomes (2013) 0.79
Estimating the incidence of connective tissue diseases and vasculitides in a defined population in Northern Savo area in 2010. Rheumatol Int (2016) 0.78
Longitudinal analysis of quality of life in patients with undifferentiated connective tissue diseases. Patient Relat Outcome Meas (2017) 0.75
Clinical characteristics and survival in idiopathic pulmonary fibrosis and connective tissue disease-associated usual interstitial pneumonia. J Thorac Dis (2015) 0.75
Undifferentiated vasculitis or an evolving systemic autoimmune rheumatic disease? Oxf Med Case Reports (2016) 0.75
Hypoxemia and arrhythmia during daily activities and six-minute walk test in fibrotic interstitial lung diseases. J Korean Med Sci (2011) 0.75
The Avise Lupus Test and Cell-bound Complement Activation Products Aid the Diagnosis of Systemic Lupus Erythematosus. Open Rheumatol J (2016) 0.75
Diagnostic uncertainty and epistemologic humility. Clin Rheumatol (2017) 0.75
Lung involvement in "stable" undifferentiated connective tissue diseases: a rheumatology perspective. Clin Rheumatol (2017) 0.75
American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Arthritis Rheum (2011) 6.28
Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum (2002) 5.12
American College of Rheumatology/European League against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Ann Rheum Dis (2011) 4.15
Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients. Medicine (Baltimore) (2002) 2.86
Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein. J Exp Med (2002) 2.64
Ankylosing spondylitis: how diagnostic and therapeutic delay have changed over the last six decades. Clin Exp Rheumatol (2012) 2.56
Adverse events during longterm low-dose glucocorticoid treatment of polymyalgia rheumatica: a retrospective study. J Rheumatol (2012) 2.27
Steroid hormones and disease activity during pregnancy in systemic lupus erythematosus. Arthritis Rheum (2002) 2.23
Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis. Ann Rheum Dis (2012) 2.21
Clinical and echocardiographic correlations of exercise-induced pulmonary hypertension in systemic sclerosis: a multicenter study. Am Heart J (2012) 2.05
Autophagy in human health and disease. N Engl J Med (2013) 2.04
Accelerated atherosclerosis in autoimmune rheumatic diseases. Circulation (2005) 2.03
Cyclophosphamide pulse regimen in the treatment of alveolitis in systemic sclerosis. J Rheumatol (2002) 1.97
Assessment of patients with systemic lupus erythematosus and the use of lupus disease activity indices. Best Pract Res Clin Rheumatol (2005) 1.94
Anti-thyroid antibodies and thyroid dysfunction in rheumatoid arthritis: prevalence and clinical value. Autoimmunity (2008) 1.90
Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: combined results from two phase III trials. Ann Rheum Dis (2012) 1.85
Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis Res Ther (2006) 1.78
Pregnancy in women with pre-existing lupus nephritis: predictors of fetal and maternal outcome. Nephrol Dial Transplant (2008) 1.77
Autoimmunity and anti-TNF-alpha agents. Ann N Y Acad Sci (2005) 1.63
Helicobacter pylori serology in autoimmune diseases - fact or fiction? Clin Chem Lab Med (2013) 1.56
The kaleidoscope of glucorticoid effects on immune system. Autoimmun Rev (2011) 1.47
Classification criteria for Sjogren's syndrome: a critical review. J Autoimmun (2011) 1.46
Treat-to-target in systemic lupus erythematosus: recommendations from an international task force. Ann Rheum Dis (2014) 1.45
Infections and autoimmunity: the multifaceted relationship. J Leukoc Biol (2009) 1.44
Novel aspects of Sjögren's syndrome in 2012. BMC Med (2013) 1.44
Isolated aortitis versus giant cell arteritis: are they really two sides of the same coin? Clin Exp Rheumatol (2014) 1.43
Performance of the preliminary classification criteria for cryoglobulinaemic vasculitis and clinical manifestations in hepatitis C virus-unrelated cryoglobulinaemic vasculitis. Clin Exp Rheumatol (2012) 1.41
Overlap of ACA-positive systemic sclerosis and Sjögren's syndrome: a distinct clinical entity with mild organ involvement but at high risk of lymphoma. Clin Exp Rheumatol (2013) 1.41
Epidemiology and management of neuropsychiatric disorders in Behçet's syndrome. CNS Drugs (2015) 1.39
EULAR Sjogren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjogren's syndrome. Ann Rheum Dis (2011) 1.37
Good clinical response, remission, and predictors of remission in rheumatoid arthritis patients treated with tumor necrosis factor-alpha blockers: the GISEA study. J Rheumatol (2007) 1.34
Retracted Drug-induced lupus erythematosus. Autoimmunity (2005) 1.31
Linkage proof for PTPN22, a rheumatoid arthritis susceptibility gene and a human autoimmunity gene. Proc Natl Acad Sci U S A (2007) 1.29
Clinical manifestations and treatment of Churg-Strauss syndrome. Rheum Dis Clin North Am (2010) 1.26
Novel biomarkers in autoimmune diseases: prolactin, ferritin, vitamin D, and TPA levels in autoimmune diseases. Ann N Y Acad Sci (2007) 1.26
Autoantibodies in polymyositis and dermatomyositis. Curr Rheumatol Rep (2013) 1.25
Genes, epigenetic regulation and environmental factors: which is the most relevant in developing autoimmune diseases? Autoimmun Rev (2011) 1.25
Proteome analysis of whole saliva: a new tool for rheumatic diseases--the example of Sjögren's syndrome. Proteomics (2007) 1.23
Accuracy of anti-ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus: an international meta-analysis. Arthritis Rheum (2006) 1.21
Ultrasound lung comets in systemic sclerosis: a chest sonography hallmark of pulmonary interstitial fibrosis. Rheumatology (Oxford) (2009) 1.16
"To be or not to be," ten years after: evidence for mixed connective tissue disease as a distinct entity. Semin Arthritis Rheum (2011) 1.15
Autoantibodies against protective molecules--C1q, C-reactive protein, serum amyloid P, mannose-binding lectin, and apolipoprotein A1: prevalence in systemic lupus erythematosus. Ann N Y Acad Sci (2007) 1.15
The ITGAV rs3738919-C allele is associated with rheumatoid arthritis in the European Caucasian population: a family-based study. Arthritis Res Ther (2007) 1.12
Environment and systemic lupus erythematosus: an overview. Autoimmunity (2005) 1.12
Incident comorbidity among patients with rheumatoid arthritis treated or not with low-dose glucocorticoids: a retrospective study. J Rheumatol (2010) 1.12
Anti-Mi-2 antibodies. Autoimmunity (2005) 1.10
Undifferentiated CTD: a wide spectrum of autoimmune diseases. Best Pract Res Clin Rheumatol (2012) 1.10
Prevalence and clinico-serological correlations of anti-alpha-enolase, anti-C1q, and anti-dsDNA antibodies in patients with systemic lupus erythematosus. J Rheumatol (2006) 1.10
A randomized pilot trial comparing cyclosporine and azathioprine for maintenance therapy in diffuse lupus nephritis over four years. Clin J Am Soc Nephrol (2006) 1.09
Proteomic analysis of saliva: a unique tool to distinguish primary Sjögren's syndrome from secondary Sjögren's syndrome and other sicca syndromes. Arthritis Res Ther (2011) 1.08
Long-term outcomes in difficult-to-treat patients with recurrent pericarditis. Am J Cardiol (2006) 1.07
Rate of serious infections in patients with rheumatoid arthritis receiving tumor necrosis factor (TNF)-alpha antagonist: a prospective observational study. Joint Bone Spine (2014) 1.07
Risk factors for pregnancy failure in patients with anti-phospholipid syndrome treated with conventional therapies: a multicentre, case-control study. Rheumatology (Oxford) (2011) 1.06
Hormones, immune response, and pregnancy in healthy women and SLE patients. Swiss Med Wkly (2010) 1.06
Overlap connective tissue disease syndromes. Autoimmun Rev (2012) 1.05
Human papillomavirus vaccine and systemic lupus erythematosus. Clin Rheumatol (2013) 1.05
Large- and small-vessel vasculitis: a critical digest of the 2010-2011 literature. Clin Exp Rheumatol (2012) 1.05
Pregnancy, cytokines, and disease activity in systemic lupus erythematosus. Arthritis Rheum (2004) 1.04
Factors and comorbidities associated with first neuropsychiatric event in systemic lupus erythematosus: does a risk profile exist? A large multicentre retrospective cross-sectional study on 959 Italian patients. Rheumatology (Oxford) (2011) 1.04
Diagnostic performance and validation of autoantibody testing in myositis by a commercial line blot assay. Rheumatology (Oxford) (2010) 1.04
Treatment strategy in fibromyalgia syndrome: where are we now? Semin Arthritis Rheum (2007) 1.03
Does seronegative antiphospholipid syndrome really exist? Autoimmun Rev (2011) 1.03
Systematic literature review on economic implications and pharmacoeconomic issues of rheumatoid arthritis. Clin Exp Rheumatol (2012) 1.02
Anti-dsDNA antibody isotypes in systemic lupus erythematosus: IgA in addition to IgG anti-dsDNA help to identify glomerulonephritis and active disease. PLoS One (2013) 1.01
Potential target of infliximab in autoimmune and inflammatory diseases. Autoimmun Rev (2007) 1.00
Thyroid cancer in systemic lupus erythematosus: a case-control study. J Clin Endocrinol Metab (2009) 1.00
Risk factors for a first thrombotic event in antiphospholipid antibody carriers: a prospective multicentre follow-up study. Ann Rheum Dis (2011) 1.00
Undifferentiated connective tissue diseases (UCTD): simplified systemic autoimmune diseases. Autoimmun Rev (2010) 1.00
SERPINB3, apoptosis and autoimmunity. Autoimmun Rev (2009) 0.99
Renal flares in 91 SLE patients with diffuse proliferative glomerulonephritis. Kidney Int (2002) 0.99
Mycophenolate mofetil: what is its place in the treatment of autoimmune rheumatic diseases? Autoimmun Rev (2006) 0.98
Autoantibodies and prediction of reproductive failure. Am J Reprod Immunol (2006) 0.98
Prevalence of thyroid dysfunctions in systemic lupus erythematosus. Metabolism (2009) 0.98
Chronic fatigue syndrome: characteristics and possible causes for its pathogenesis. Isr Med Assoc J (2008) 0.98
Sjögren's Syndrome Disease Damage Index and disease activity index: scoring systems for the assessment of disease damage and disease activity in Sjögren's syndrome, derived from an analysis of a cohort of Italian patients. Arthritis Rheum (2007) 0.98
Disease activity patterns in a monocentric cohort of SLE patients: a seven-year follow-up study. Clin Exp Rheumatol (2012) 0.98
Five-year follow-up by transesophageal echocardiographic studies in primary antiphospholipid syndrome. Am J Cardiol (2005) 0.96
Current state and future directions of autologous hematopoietic stem cell transplantation in systemic lupus erythematosus. Ann Rheum Dis (2011) 0.96
Non-invasive assessment of coronary flow reserve and ADMA levels: a case-control study of early rheumatoid arthritis patients. Rheumatology (Oxford) (2009) 0.96
Potential cost-effectiveness of a preventive hepatitis C vaccine in high risk and average risk populations in Canada. Vaccine (2005) 0.95
Undifferentiated connective tissue diseases (UCTD): a new frontier for rheumatology. Best Pract Res Clin Rheumatol (2007) 0.95
Prevalence of hepatitis C serum antibody in autoimmune diseases. J Autoimmun (2009) 0.94
Myofiber stress-response in myositis: parallel investigations on patients and experimental animal models of muscle regeneration and systemic inflammation. Arthritis Res Ther (2010) 0.94
Prolactin and autoimmunity: hyperprolactinemia correlates with serositis and anemia in SLE patients. Clin Rev Allergy Immunol (2012) 0.94
Proteomic diagnosis of Sjögren's syndrome. Expert Rev Proteomics (2007) 0.94
A model of anti-angiogenesis: differential transcriptosome profiling of microvascular endothelial cells from diffuse systemic sclerosis patients. Arthritis Res Ther (2006) 0.94
Primary Sjogren's syndrome as a multi-organ disease: impact of the serological profile on the clinical presentation of the disease in a large cohort of Italian patients. Rheumatology (Oxford) (2013) 0.94
Treatment strategies and pregnancy outcomes in antiphospholipid syndrome patients with thrombosis and triple antiphospholipid positivity. A European multicentre retrospective study. Thromb Haemost (2014) 0.93
Specific proteins identified in whole saliva from patients with diffuse systemic sclerosis. J Rheumatol (2007) 0.93